MIK Trademark

Trademark Overview

On Friday, April 28, 2023, a trademark application was filed for MIK with the United States Patent and Trademark Office. The USPTO has given the MIK trademark a serial number of 97911932. The federal status of this trademark filing is FIRST EXTENSION - GRANTED as of Tuesday, July 8, 2025. This trademark is owned by Emmetrope Ophthalmics LLC. The MIK trademark is filed in the Pharmaceutical Products category with the following description:

Biological tissue cultures for medical purposes; Biological tissue grafts; Biological implants, namely, a vital processed human or animal connective tissue; Biological cultured tissue for medical purposes intended for subsequent implantation
mik

General Information

Serial Number97911932
Word MarkMIK
Filing DateFriday, April 28, 2023
Status730 - FIRST EXTENSION - GRANTED
Status DateTuesday, July 8, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 3, 2024

Trademark Statements

Goods and ServicesBiological tissue cultures for medical purposes; Biological tissue grafts; Biological implants, namely, a vital processed human or animal connective tissue; Biological cultured tissue for medical purposes intended for subsequent implantation
Pseudo MarkMINIMALLY INVASIVE KERATOPLASTY

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, May 26, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameEmmetrope Ophthalmics LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressMenlo Park, CA 94025
Party NameEmmetrope Ophthalmics LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressMenlo Park, CA 94025

Trademark Events

Event DateEvent Description
Tuesday, May 2, 2023NEW APPLICATION ENTERED
Friday, May 26, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, January 16, 2024ASSIGNED TO EXAMINER
Tuesday, January 23, 2024NON-FINAL ACTION WRITTEN
Tuesday, January 23, 2024NON-FINAL ACTION E-MAILED
Tuesday, January 23, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, March 18, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, March 18, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, March 18, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, April 16, 2024NON-FINAL ACTION WRITTEN
Tuesday, April 16, 2024NON-FINAL ACTION E-MAILED
Tuesday, April 16, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, July 15, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, July 15, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, August 21, 2024FINAL REFUSAL E-MAILED
Monday, July 15, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, August 21, 2024NOTIFICATION OF FINAL REFUSAL EMAILED
Tuesday, October 8, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, August 21, 2024FINAL REFUSAL WRITTEN
Tuesday, October 8, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, October 8, 2024TEAS REQUEST FOR RECONSIDERATION RECEIVED
Thursday, November 7, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, January 14, 2025NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 8, 2025SOU TEAS EXTENSION RECEIVED
Tuesday, July 8, 2025SOU EXTENSION 1 FILED
Tuesday, July 8, 2025SOU EXTENSION 1 GRANTED
Wednesday, July 9, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 3, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, November 27, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 3, 2024PUBLISHED FOR OPPOSITION

Related Keywords

biological tissue medical purposes implantation connective cultured intended subsequent animal